Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Wheeler Kurt
Relationship:   10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   8,638,466    

Indirect Shares

  50,230,112      
Direct Value   $53,673,527    

Indirect Value

  $221,892,016      
Total Shares   58,868,578      
Total Value   $275,565,543      


Rigel Pharmaceuticals Inc
 $4,407,795 Somaxon Pharmaceuticals, Inc.
 $0 Oxford Immunotec Global Plc
 $49,199,920 Sientra, Inc.
 $65,811 Rigel Pharmaceuticals Inc
 $4,407,795 Somaxon Pharmaceuticals, Inc.
 $0 Oxford Immunotec Global Plc
 $49,199,920 Sientra, Inc.
 $65,811
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    6    

     Stock price went up :

    1   
    6    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   6.0   
     Percentage Gain/Loss :
   12.5%
 44.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rigel Pharmaceuticals Inc RIGL 10% Owner 2003-06-26 3,612,947 2004-09-13 475,026    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC 10% Owner 0 2004-03-16 87,899    Premium*  
            Hemosense Inc HEM Director, 10% Owner 2005-07-01 0 2007-11-06 0    Premium*  
            American Cryostem Corporation CRYO Director, 10% Owner 2005-07-13 0 2008-05-28 0    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX Director, 10% Owner 2009-12-31 57,377 2009-12-31 4,632,562    Premium*  
            Poniard Pharmaceuticals PARD 10% Owner 0 2009-11-09 6,363,249    Premium*  
            Affymax Inc AFFY 10% Owner 0 2006-12-20 1,600,469    Premium*  
            Helicos Biosciences Corp HLCSQ 10% Owner 2007-05-30 0 2007-05-30 2,987,769    Premium*  
            Ithaka Acquisition Corp ITHKU Director, 10% Owner 0 2007-06-21 2,672,568    Premium*  
            Aryx Therapeutics Inc ARYX 10% Owner 2007-11-13 0 2008-11-14 5,364,572    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 0 2011-10-27 11,133,961    Premium*  
            Aveo Pharmaceuticals Inc AVEO Former 10% Stockholder 2010-03-17 0 2010-03-17 2,208,961    Premium*  
            Zogenix, Inc. ZGNX Director, 10% Owner 2010-11-29 0 2010-11-29 5,982,439    Premium*  
            Humanigen Inc HGEN 10% Owner 2013-02-05 0 2013-02-05 2,632,928    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2015-01-28 0 2013-10-25 0    Premium*  
            Oxford Immunotec Global Plc OXFD 10% Owner 2015-06-16 2,237,377 2013-11-22 0    Premium*  
            Radius Health Inc. RDUS Former 10% stockholder 2014-06-06 0 2016-09-27 2,459,804    Premium*  
            Iveric Bio Inc ISEE 10% Owner 2015-05-26 0 2014-06-11 4,500    Premium*  
            Sientra, Inc. SIEN 10% Owner 2014-10-28 2,730,765 0    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2018-09-28 0 2018-09-28 1,623,405    Premium*  
* Premium Members only  

Records found :    137         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
OXFD Oxford Immunotec Global P... 10% Owner   –       –       •   2015-03-23 4 S $14.44 $379,772 D/D (26,300) 2,371,328 0 -
OXFD Oxford Immunotec Global P... 10% Owner   –       –       •   2015-03-20 4 S $14.53 $393,981 D/D (27,115) 2,397,628 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-20 4 S $21.84 $600,619 I/I (27,499) 1,772,925 -
ISEE Iveric Bio Inc 10% Owner   –       –       •   2014-06-11 4 S $44.53 $1,301,074 D/D (29,217) 2,843,564 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-22 4 S $15.51 $462,153 I/I (29,805) 3,461,158 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •       •   2007-05-01 4 AS $18.07 $576,968 I/I (31,925) 3,433,344 0 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2011-10-05 4 S $1.02 $33,786 I/I (33,124) 14,013,729 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2009-03-31 4 A $0.00 $0 D/D 33,214 33,757 0 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2011-10-19 4 S $1.02 $35,513 I/I (34,817) 12,901,068 0 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2011-10-14 4 S $1.02 $40,494 I/I (39,700) 12,955,529 0 -
OXFD Oxford Immunotec Global P... 10% Owner   –       –       •   2015-06-16 4 S $14.30 $567,724 D/D (39,701) 2,237,377 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •       •   2007-04-27 4 AS $18.07 $778,778 I/I (43,100) 3,484,769 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-12-22 4 S $30.36 $1,501,029 D/D (49,441) 3,603,866 0 -
OXFD Oxford Immunotec Global P... 10% Owner   –       –       •   2015-03-19 4 S $14.61 $730,675 D/D (50,012) 2,424,743 0 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2011-09-29 4 S $1.02 $54,876 I/I (53,800) 14,070,161 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-25 4 S $15.80 $861,182 I/I (54,500) 3,336,463 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-31 4 S $20.60 $1,246,626 I/I (60,527) 1,711,572 -
ISEE Iveric Bio Inc 10% Owner   –       –       •   2014-06-09 4 S $46.02 $3,023,963 D/D (65,059) 2,989,685 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-24 4 S $15.54 $1,084,850 I/I (69,807) 3,390,963 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2011-10-21 4 S $1.02 $71,502 I/I (70,100) 12,405,968 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •       •   2007-05-08 4 AS $18.23 $1,329,317 I/I (72,900) 3,355,969 0 -
AFFY Affymax Inc 10% Owner   –       –       •   2006-12-19 4 D $25.00 $1,823,575 I/I (72,943) 65,571 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-12-26 4 S $30.05 $2,239,026 D/D (74,510) 3,529,093 0 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2011-10-26 4 S $1.02 $79,560 I/I (78,000) 11,872,768 0 -
PARD Poniard Pharmaceuticals 10% Owner   –       –       •   2009-11-05 4 S $8.00 $626,292 I/I (78,262) 6,779,949 0 -

  137  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed